Literature DB >> 25560385

Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanism.

Brian León1, Gabriel Navarro, Bailey J Dickey, George Stepan, Angela Tsai, Gregg S Jones, Monica E Morales, Tiffany Barnes, Shekeba Ahmadyar, Manuel Tsiang, Romas Geleziunas, Tomas Cihlar, Nikos Pagratis, Yang Tian, Helen Yu, Roger G Linington.   

Abstract

Screening of a marine natural products library afforded three new analogues of the tetronic acid containing polyketide abyssomicin family and identified abyssomicin 2 as a selective reactivator of latent HIV virus. Examination of the mode of action of this new latent HIV reactivating agent demonstrated that it functions via a distinct mechanism compared to that of existing reactivating agents and is effective at reactivating latent virus in a subset of primary patient cell lines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25560385      PMCID: PMC5755699          DOI: 10.1021/ol503349y

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  26 in total

1.  Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway.

Authors:  Bojan Bister; Daniel Bischoff; Markus Ströbele; Julia Riedlinger; Andreas Reicke; Falko Wolter; Alan T Bull; Hans Zähner; Hans-Peter Fiedler; Roderich D Süssmuth
Journal:  Angew Chem Int Ed Engl       Date:  2004-05-03       Impact factor: 15.336

2.  Action of atrop-abyssomicin C as an inhibitor of 4-amino-4-deoxychorismate synthase PabB.

Authors:  Simone Keller; Heiko S Schadt; Ingo Ortel; Roderich D Süssmuth
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 3.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

Review 4.  Cardiovascular risks of antiretroviral therapies.

Authors:  Kristin Mondy; Pablo Tebas
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

5.  Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

Authors:  Ginger Lehrman; Ian B Hogue; Sarah Palmer; Cheryl Jennings; Celsa A Spina; Ann Wiegand; Alan L Landay; Robert W Coombs; Douglas D Richman; John W Mellors; John M Coffin; Ronald J Bosch; David M Margolis
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

6.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Authors:  Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

7.  Synthesis of the carbocyclic skeleton of abyssomicins C and D.

Authors:  Barry B Snider; Yefen Zou
Journal:  Org Lett       Date:  2005-10-27       Impact factor: 6.005

8.  Discoveries from the Abyss: The Abyssomicins and Their Total Synthesis.

Authors:  K C Nicolaou; Scott T Harrison; Jason S Chen
Journal:  Synthesis (Stuttg)       Date:  2009-01-01       Impact factor: 3.157

9.  Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: natural thioether Michael addition adducts as antitubercular prodrugs.

Authors:  Qian Wang; Fuhang Song; Xue Xiao; Pei Huang; Li Li; Aaron Monte; Wael M Abdel-Mageed; Jian Wang; Hui Guo; Wenni He; Feng Xie; Huanqin Dai; Miaomiao Liu; Caixia Chen; Hao Xu; Mei Liu; Andrew M Piggott; Xueting Liu; Robert J Capon; Lixin Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-06       Impact factor: 15.336

10.  New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Authors:  C Korin Bullen; Gregory M Laird; Christine M Durand; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

View more
  9 in total

1.  Bi- and Tetracyclic Spirotetronates from the Coal Mine Fire Isolate Streptomyces sp. LC-6-2.

Authors:  Xiachang Wang; Sherif I Elshahawi; Wenlong Cai; Yinan Zhang; Larissa V Ponomareva; Xiabin Chen; Gregory C Copley; James C Hower; Chang-Guo Zhan; Sean Parkin; Jürgen Rohr; Steven G Van Lanen; Khaled A Shaaban; Jon S Thorson
Journal:  J Nat Prod       Date:  2017-03-30       Impact factor: 4.050

2.  Phenogenomic Characterization of a Newly Domesticated and Novel Species from the Genus Verrucosispora.

Authors:  Sarah J Kennedy; Celine Grace F Atkinson; Brooke R Tomlinson; Lauren Hammond; Prahathees Eswara; Bill J Baker; Lindsey N Shaw
Journal:  Appl Environ Microbiol       Date:  2021-09-08       Impact factor: 4.792

3.  Characterization and heterologous expression of the neoabyssomicin/abyssomicin biosynthetic gene cluster from Streptomyces koyangensis SCSIO 5802.

Authors:  Jiajia Tu; Siting Li; Jiang Chen; Yongxiang Song; Shaobin Fu; Jianhua Ju; Qinglian Li
Journal:  Microb Cell Fact       Date:  2018-02-20       Impact factor: 5.328

Review 4.  Review on Abyssomicins: Inhibitors of the Chorismate Pathway and Folate Biosynthesis.

Authors:  Carmen Sadaka; Edmund Ellsworth; Paul Robert Hansen; Richard Ewin; Peter Damborg; Jeffrey L Watts
Journal:  Molecules       Date:  2018-06-06       Impact factor: 4.411

Review 5.  Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

6.  Out of the Abyss: Genome and Metagenome Mining Reveals Unexpected Environmental Distribution of Abyssomicins.

Authors:  Alba Iglesias; Adriel Latorre-Pérez; James E M Stach; Manuel Porcar; Javier Pascual
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

Review 7.  Recent progresses in marine microbial-derived antiviral natural products.

Authors:  Yun-Fei Teng; Li Xu; Mei-Yan Wei; Chang-Yun Wang; Yu-Cheng Gu; Chang-Lun Shao
Journal:  Arch Pharm Res       Date:  2020-11-21       Impact factor: 4.946

Review 8.  Abyssomicins-A 20-Year Retrospective View.

Authors:  Hans-Peter Fiedler
Journal:  Mar Drugs       Date:  2021-05-24       Impact factor: 5.118

9.  The crystal structure of AbsH3: A putative flavin adenine dinucleotide-dependent reductase in the abyssomicin biosynthesis pathway.

Authors:  Jonathan A Clinger; Xiachang Wang; Wenlong Cai; Yanyan Zhu; Mitchell D Miller; Chang-Guo Zhan; Steven G Van Lanen; Jon S Thorson; George N Phillips
Journal:  Proteins       Date:  2020-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.